Skip to content
Search

Latest Stories

Exclusive: Artificial pancreas trial hailed as ‘new era for healthcare’

Exclusive: Artificial pancreas trial hailed as ‘new era for healthcare’

AN artificial pancreas trial currently running in the UK will help the healthcare sector leap to a new digital era, the NHS national speciality adviser for diabetes has said.

As many as 1,000 NHS patients with type 1 diabetes are taking part in a study where their blood sugar levels will be monitored and the amount of insulin given via a pump will be automatically adjusted. The trial started on July 19 at 25 adult centres, and six paediatric centres around the country; it is expected to be completed by August 2022.


Professor Partha Kar told Eastern Eye, “Patients can go home after the set-up is done (at a clinic). We can monitor data remotely, from the clinic. This will be the first trial of this kind and be the future for clinical trials going ahead. I think this’ll be a new digital chapter for the healthcare sector.

PSK pcture Professor Partha Kar

“The pandemic has fastened the change. And I think this is a good start.”

People with type 1 diabetes – who comprise eight per cent of people with diabetes in the UK - cannot produce enough insulin. They need daily doses of the hormone to keep blood sugar levels under control, delivered via an injector pen or a pump.

Under the new ‘closed loop technology’ trial, finger prick tests can be eliminated, and life-threatening hypoglycaemic attacks could be prevented.

Kar explained how the technology works.

“It’s called an artificial pancreas. We want to see whether we can create what the pancreas does inside the body. You have a sensor on the arm with a little pump on the hip.

“Instead of pricking your finger, you have a sensor that picks up the glucose level and that reading is transmitted to your insulin pump. You don't have to inject the insulin as the pump will work out how much insulin is needed and give you the necessary quantity,” Kar told Eastern Eye.

According to him, in the past three or four years, several companies have been developing artificial pancreas technology.

“But the issue is that you can't fund it without the evidence. So that’s what we're doing. We are saying, ‘let's put 1000 patients around the country- with different age groups, different needs - on this artificial pancreas. And let's see the result. Does it improve their glucose level, their quality of life? That’s what we are trying to find out through this trial.”

Medtronic, Tandem Diabetes Care, Dana (with Prof Roman Hovorka engineered algorithm) and Medtrum are the four major companies in the UK engaged in the development of the artificial pancreas.

Kar described the ongoing trial as crucial for diabetes treatment.

“The artificial pancreas trial is for type 1 diabetes patients. A positive outcome for this project can give a permanent solution to the disease. Then the healthcare sector can concentrate on type 2 diabetes, which is a bigger problem,” he said.

Type 2 diabetes is a lifelong disease where the insulin (which regulates blood sugar levels) is not effective and leads to high sugar in the blood. People with type 2 diabetes are said to have insulin resistance.

Kar said, “In UK about seven per cent of the population has type 2 diabetes. In India, it's a rising issue simply because of the higher risk of our ethnicity. More south Asian people in the UK are at risk.

“Our diet, lifestyle, consumption of sweets during religious festivals can lead to more people towards having type 2 diabetes. It is a rising issue. South Asians in the UK have got a higher prevalence of type 2 diabetes than the average (white) population.

“Look at the data around Covid - people with diabetes were severely affected by the pandemic. The ongoing trial, I think, will create awareness about diabetes among people, irrespective of the type, which is a good thing.”

Kar pointed out that diagnosis of type 2 diabetes among younger people in the UK is an alarming trend due to modern lifestyle and lack of exercise.

However, the national diabetic adviser cautioned against drawing simplistic conclusions.

“What people should not assume is that if you have type 1 diabetes and you have an ‘artificial pancreas’, everything is sorted. Absolutely not. You still need a healthy lifestyle. It doesn't matter how artificial your pancreas is, without the right food and lifestyle you are at risk.”

More For You

Starmer Mandelson

Starmer talks with Mandelson during a welcome reception at the ambassador's residence on February 26, 2025 in Washington, DC.

Getty

Starmer under pressure from party MPs after Mandelson dismissal

PRIME MINISTER Keir Starmer is facing questions within the Labour party after the sacking of US ambassador Peter Mandelson.

Mandelson was removed last week after Bloomberg published emails showing messages of support he sent following Jeffrey Epstein’s conviction for sex offences. The dismissal comes just ahead of US president Donald Trump’s state visit.

Keep ReadingShow less
Nepal’s new leader pledges to act on Gen Z calls to end corruption

Officials greet newly-elected Prime Minister of Nepal's interim government Sushila Karki (R) as she arrives at the prime minister's office in Kathmandu on September 14, 2025. (Photo by PRABIN RANABHAT/AFP via Getty Images)

Nepal’s new leader pledges to act on Gen Z calls to end corruption

NEPAL’s new interim prime minister Sushila Karki on Sunday (14) pledged to act on protesters’ calls to end corruption and restore trust in government, as the country struggles with the aftermath of its worst political unrest in decades.

“We have to work according to the thinking of the Gen Z generation,” Karki said in her first address to the nation since taking office on Friday (12). “What this group is demanding is the end of corruption, good governance and economic equality. We will not stay here more than six months in any situation. We will complete our responsibilities and hand over to the next parliament and ministers.”

Keep ReadingShow less
UK secures £1.25bn US investment ahead of Trump’s visit

US president Donald Trump and UK prime minister Sir Keir Starmer arrive at Trump International Golf Links on July 28, 2025 in Balmedie, Scotland. (Photo by Jane Barlow-WPA Pool/Getty Images)

UK secures £1.25bn US investment ahead of Trump’s visit

THE British government has announced over £1.25 billion ($1.69bn) in fresh investment from major US financial firms, including PayPal, Bank of America, Citigroup and S&P Global, ahead of a state visit by president Donald Trump.

The investment is expected to create 1,800 jobs across London, Edinburgh, Belfast and Manchester, and deepen transatlantic financial ties, the Department for Business and Trade said.

Keep ReadingShow less
Nearly 150,000 join anti-migrant protest in London as clashes erupt

Protesters wave Union Jack and St George's England flags during the "Unite The Kingdom" rally on Westminster Bridge by the Houses of Parliament on September 13, 2025 in London, England. (Photo by Christopher Furlong/Getty Images)

Nearly 150,000 join anti-migrant protest in London as clashes erupt

MORE THAN 100,000 protesters marched through central London on Saturday (13), carrying flags of England and Britain and scuffling with police in one of the UK's biggest right-wing demonstrations of modern times.

London's Metropolitan Police said the "Unite the Kingdom" march, organised by anti-immigrant activist Tommy Robinson, was attended by nearly 150,000 people, who were kept apart from a "Stand Up to Racism" counter-protest attended by around 5,000.

Keep ReadingShow less
Piyush Goyal

Piyush Goyal recalled that in February, Narendra Modi and Donald Trump had instructed their trade ministers to conclude the first phase of the bilateral trade agreement (BTA) by November 2025. (Photo: Getty Images)

Getty Images

Trade talks with US moving forward positively, says Indian minister Goyal

INDIA’s commerce and industry minister Piyush Goyal on Thursday said that negotiations on the proposed trade agreement between India and the United States, which began in March, are progressing in a positive atmosphere and both sides are satisfied with the discussions.

He recalled that in February, Indian prime minister Narendra Modi and US president Donald Trump had instructed their trade ministers to conclude the first phase of the bilateral trade agreement (BTA) by November 2025.

Keep ReadingShow less